ES2344150T3 - Procedimientos y reactivos para diagnosticar la infeccion por hantavirus. - Google Patents

Procedimientos y reactivos para diagnosticar la infeccion por hantavirus. Download PDF

Info

Publication number
ES2344150T3
ES2344150T3 ES05856748T ES05856748T ES2344150T3 ES 2344150 T3 ES2344150 T3 ES 2344150T3 ES 05856748 T ES05856748 T ES 05856748T ES 05856748 T ES05856748 T ES 05856748T ES 2344150 T3 ES2344150 T3 ES 2344150T3
Authority
ES
Spain
Prior art keywords
seq
hantavirus
antigen
baselineskip
antigens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES05856748T
Other languages
English (en)
Spanish (es)
Inventor
Steve H. NGUYEN
Sergio PICHUANTES
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Novartis Vaccines and Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Vaccines and Diagnostics Inc filed Critical Novartis Vaccines and Diagnostics Inc
Application granted granted Critical
Publication of ES2344150T3 publication Critical patent/ES2344150T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/175—Bunyaviridae, e.g. California encephalitis virus, Rift valley fever virus, Hantaan virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/12011—Bunyaviridae
    • C12N2760/12111—Hantavirus, e.g. Hantaan virus
    • C12N2760/12122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ES05856748T 2004-06-18 2005-05-24 Procedimientos y reactivos para diagnosticar la infeccion por hantavirus. Expired - Lifetime ES2344150T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58102704P 2004-06-18 2004-06-18
US581027P 2004-06-18

Publications (1)

Publication Number Publication Date
ES2344150T3 true ES2344150T3 (es) 2010-08-19

Family

ID=36916873

Family Applications (1)

Application Number Title Priority Date Filing Date
ES05856748T Expired - Lifetime ES2344150T3 (es) 2004-06-18 2005-05-24 Procedimientos y reactivos para diagnosticar la infeccion por hantavirus.

Country Status (9)

Country Link
US (3) US7771730B2 (https=)
EP (1) EP1778880B1 (https=)
JP (2) JP4813471B2 (https=)
KR (1) KR20070026802A (https=)
CN (1) CN101163498B (https=)
AT (1) ATE469656T1 (https=)
DE (1) DE602005021644D1 (https=)
ES (1) ES2344150T3 (https=)
WO (1) WO2006088478A2 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2431148C1 (ru) * 2010-05-05 2011-10-10 Евгений Александрович Ткаченко Способ получения "диагностикума геморрагической лихорадки с почечным синдромом культурального, поливалентного для непрямого метода иммунофлюоресценции"
WO2012083475A1 (es) * 2010-12-20 2012-06-28 Universidad De Desarollo Anticuerpo policlonal neutralizante contra hantavirus andes, procedimiento de producción y composiciones farmacéuticas
CN112812184A (zh) 2011-02-25 2021-05-18 中外制药株式会社 FcγRIIb特异性Fc抗体
JP6322411B2 (ja) 2011-09-30 2018-05-09 中外製薬株式会社 複数の生理活性を有する抗原の消失を促進する抗原結合分子
CN102399265B (zh) * 2011-10-28 2014-06-25 中国人民解放军第四军医大学 Htnv-np 特异性的ctl 表位肽及其应用
RU2590606C2 (ru) * 2012-04-12 2016-07-10 Федеральное государственное бюджетное учреждение "Институт полиомиелита и вирусных энцефалитов им. М.П. Чумакова РАМН" Способ получения тест-системы "ханта-n" для определения специфической активности вакцины против геморрагической лихорадки с почечным синдромом
CN102731617B (zh) * 2012-05-05 2013-11-27 中国人民解放军第四军医大学 汉滩病毒糖蛋白特异性t细胞表位肽及其应用
RU2484478C1 (ru) * 2012-05-11 2013-06-10 Государственное бюджетное образовательное учреждение дополнительного профессионального образования "Казанская государственная медицинская академия" Министерства здравоохранения и социального развития Российской Федерации Способ обнаружения антител к хантавирусу при геморрагической лихорадке с почечным синдромом и прогнозирование тяжелых форм заболевания
EP2857419B1 (en) * 2012-05-30 2021-01-13 Chugai Seiyaku Kabushiki Kaisha Antigen-binding molecule for eliminating aggregated antigens
CN102731623B (zh) * 2012-06-08 2013-09-18 中国人民解放军第四军医大学 鼠源性单克隆抗体3d8识别的汉滩病毒糖蛋白中和表位肽及应用
NL2009515C2 (en) * 2012-09-25 2014-03-27 Europ Intelligence B V Mooring device for mooring a ship.
AU2014250434B2 (en) 2013-04-02 2019-08-08 Chugai Seiyaku Kabushiki Kaisha Fc region variant
RU2565543C2 (ru) * 2013-04-10 2015-10-20 Федеральное государственное бюджетное научное учреждение "Институт полиомиелита и вирусных энцефалитов им М.П. Чумакова " Способ получения иммуноферментной тест-системы для определения эпитопов оболочечного белка вируса пуумала протективной направленности в вакцинных препаратах против геморрагической лихорадки с почечным синдромом
US20140378329A1 (en) * 2013-06-24 2014-12-25 Idexx Laboratories, Inc. Animal Colony Monitoring Using Fecal Samples
CN106046125B (zh) * 2016-06-30 2020-04-24 中国人民解放军第四军医大学 Htnv gp上的ctl表位肽及其筛选方法和应用
KR102013954B1 (ko) * 2016-12-26 2019-08-23 주식회사 이뮨메드 서울바이러스와 푸말라바이러스 유래의 재조합 뉴클레오캡시드 단백질 및 한탄바이러스 유래의 재조합 당단백질을 포함하는 신증후군출혈열 진단용 조성물 및 이를 포함하는 진단 키트
CN107383176A (zh) * 2017-05-10 2017-11-24 于学杰 用于对汉滩病毒和汉城病毒引起的肾综合征出血热分型的多肽
CN110548136A (zh) * 2018-05-30 2019-12-10 王美亮 汉坦病毒长肽疫苗
CN109852588B (zh) * 2018-12-24 2023-03-07 中国水产科学研究院珠江水产研究所 一种抗罗非鱼免疫球蛋白IgM的单克隆抗体及其细胞株和应用
CN110042173A (zh) * 2019-02-28 2019-07-23 中国科学院广州生物医药与健康研究院 一种同时检测四种出血热病毒的纳米金生物传感器及检测方法
GB201910804D0 (en) * 2019-07-29 2019-09-11 Secetary Of State For Health And Socail Care Hantavirus antigenic Composition
KR102089268B1 (ko) * 2019-10-02 2020-03-16 대한민국 한탄바이러스 절단형 뉴클레오캡시드 단백질을 이용한 한탄바이러스 검출 방법
CN111333705A (zh) * 2019-12-06 2020-06-26 中国人民解放军第四军医大学 影响HTNV Gn胞质尾区的出胞表位序列的筛选及鉴定方法
CN114478719A (zh) * 2022-02-11 2022-05-13 中国人民解放军空军军医大学 一组汉坦病毒包膜糖蛋白的优势表位肽、其编码基因及应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4714556A (en) * 1981-06-29 1987-12-22 Ambrus Clara M Blood purification
US5298423A (en) 1987-11-25 1994-03-29 The United States Of America As Represented By The Secretary Of The Army Nucleotide sequences encoding the expression of a Hantaan virus nucleocapsid protein and G1 and G2 glycoproteins
JP2664471B2 (ja) * 1989-04-26 1997-10-15 鎬汪 李 腎症候性出血熱の診断用試薬
CA2166104A1 (en) * 1993-06-24 1995-01-05 Stuart T. Nichol Nucleic acids of a novel hantavirus and reagents for detection and prevention of infection
US5837441A (en) 1993-08-25 1998-11-17 University Of New Mexico Hantavirus-associated respiratory distress virus antigens
US5853980A (en) 1995-02-17 1998-12-29 The United States Of America As Represented By The Department Of Health And Human Services Black creek canal hantavirus and related methods
JPH10253634A (ja) * 1997-03-10 1998-09-25 Denki Kagaku Kogyo Kk クラミジア・トラコマティス抗体測定方法及び抗体測定試薬
US6136250A (en) * 1998-01-30 2000-10-24 Comair Rotron, Inc. Apparatus and method of encapsulating motors
US7217812B2 (en) 1999-01-29 2007-05-15 United States Of America As Represented By The Secretary Of The Army Extraneous DNA sequence that facilitates hantavirus gene expression
FR2794865B1 (fr) * 1999-06-09 2003-04-18 Pasteur Institut Methode de detection precoce des flavivirus et ses applications

Also Published As

Publication number Publication date
US7771730B2 (en) 2010-08-10
EP1778880A2 (en) 2007-05-02
JP4813471B2 (ja) 2011-11-09
DE602005021644D1 (de) 2010-07-15
WO2006088478A9 (en) 2007-03-08
US20110053140A1 (en) 2011-03-03
CN101163498B (zh) 2011-10-05
EP1778880B1 (en) 2010-06-02
US20130085264A1 (en) 2013-04-04
ATE469656T1 (de) 2010-06-15
EP1778880A4 (en) 2008-05-07
WO2006088478A3 (en) 2007-07-05
JP2008503720A (ja) 2008-02-07
KR20070026802A (ko) 2007-03-08
WO2006088478A2 (en) 2006-08-24
CN101163498A (zh) 2008-04-16
US20080108051A1 (en) 2008-05-08
JP2011191322A (ja) 2011-09-29

Similar Documents

Publication Publication Date Title
ES2344150T3 (es) Procedimientos y reactivos para diagnosticar la infeccion por hantavirus.
KR102019008B1 (ko) 메르스 코로나바이러스 뉴클레오캡시드 융합 단백질을 이용한 메르스 코로나바이러스 검출 방법
Okumura et al. Development of serological assays for Thottapalayam virus, an insectivore-borne hantavirus
JP2006527382A (ja) Ｓａｒｓコロナウイルス感染の診断方法
JP2010526880A (ja) Ｈ５トリインフルエンザの診断および監視に有用なｈ５亜型特異的結合タンパク質
US20140377740A1 (en) Soluble and membrane-anchored forms of lassa virus subunit proteins
Samuel et al. Development of a measles specific IgM ELISA for use with serum and oral fluid samples using recombinant measles nucleoprotein produced in Saccharomyces cerevisiae
ES2398413T3 (es) Kit de detección de SRSV
US20230082323A1 (en) METHODS, COMPLEXES AND KITS FOR DETECTING OR DETERMINING AN AMOUNT OF A ß CORONAVIRUS ANTIBODY IN A SAMPLE
WO2021211332A2 (en) Methods and kits for detecting or determining an amount of an anti-β-coronavirus antibody in a sample
CN115028713A (zh) 一种抗冠状病毒n蛋白的抗体及其应用
CN109970851B (zh) Ccv病毒m蛋白的单抗及其制备方法、免疫胶体金试纸条的制备方法
US6077511A (en) Antigenic peptide derived from the G protein of RSV for type- and subtype-specific diagnosis of respiratory syncytial virus (RSV) infection
ES2488849T3 (es) Anticuerpos monoclonales de conejo a antígenos de superficie de hepatitis B y métodos de utilización de los mismos
JP2006067979A (ja) インフルエンザａ型ウイルスの免疫検出法
AU2007242061B2 (en) Pestivirus species
US20220043000A1 (en) Methods and kits for detecting sars-cov-2 protein in a sample
US20240069037A1 (en) Methods for determining sars-cov-2 antigen and anti-sars-cov-2 antibody in a sample
PL205228B1 (pl) Zestaw diagnostyczny do badania surowic zwierząt na obecność przeciwciał RHD oraz zestaw diagnostyczny do wykrywania wirusa RHD
Marsh et al. Increased susceptibility of human respiratory syncytial virus to neutralization by anti‐fusion protein antibodies on adaptation to replication in cell culture
JP2005503766A (ja) ルブラウイルス（ｒｕｂｕｌａｖｉｒｕｓ）属に属するウイルス（クリプトウイルス）（ｃｒｙｐｔｏｖｉｒｕｓ）とその使用
DeSheng et al. Identification of two novel rabbit hemorrhagic disease virus (RHDV) B cell epitopes and evaluation of its immunoprotection against RHDV
KR100862084B1 (ko) 유행성이하선염 바이러스 핵단백질 및 이것의 용도
CN119192307A (zh) 一种呼吸道合胞病毒多肽抗原及其应用
HK40096253A (zh) 戊型肝炎病毒样颗粒及其用途